斯库特拉林通过TGF-β1信号通路改善糖尿病病
Bangrui Huang1,2, Rui Han1, Hong Tan1
1Department of Endocrinology, The First Affiliated Hospital of Kunming Medical University, Kunming, 650032, People's Republic of China.
Natural products and bioprospecting
|April 24, 2024
概括
布雷维斯卡平的成分斯库特拉林通过减少损伤,有效治疗糖尿病病 (DN). 它通过调节纤维化和细胞损伤所涉及的关键信号通路来起作用.
科学领域:
- 药理学和自然产品的研究.
- 腎臟病學 (nephrology) 是一種醫學.
- 生物化学 生物化学
背景情况:
- 来自Erigeron breviscapus的布雷维斯卡因显示出糖尿病病 (DN) 的潜力.
- 布雷维斯卡在DN中的特定活性化合物和机制尚未完全理解.
研究的目的:
- 研究布雷维斯卡宾成分斯库特拉林对糖尿病病的治疗作用.
- 阐明斯库特拉林在DN中的作用背后的药理机制.
主要方法:
- 在体内利用了一种链毒素诱导的糖尿病病模型.
- 评估了斯库特拉林对病理学的影响,包括蛋白尿,球膜变化,纤维化和细胞损伤.
- 研究了斯库特拉林对转化生长因子-β1 (TGF-β1),细胞外信号调节激酶 (Erk) 和Wnt/β-catenin信号通路的影响.
主要成果:
- 斯库特拉林显著改善了糖尿病病的关键特征.
- 观察到蛋白尿的减少,球扩张,中质矩阵积累和纤维化.
- 证明了对细胞损伤的保护.
结论:
- 斯库特拉林是布雷维斯卡宾的活性成分,在糖尿病病中具有显著的治疗潜力.
- 斯库特拉林通过调节TGF-β1,Erk和Wnt/β-catenin信号通路来发挥其保护作用.
更多相关视频
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
405
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
12.9K
相关概念视频
01:16TGF - β Signaling Pathway
7.3K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K
01:23Dipeptidyl Peptidase 4 Inhibitors
181
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
181